Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) EBT Margin (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed EBT Margin for 5 consecutive years, with 15991.91% as the latest value for Q4 2025.

  • Quarterly EBT Margin changed N/A to 15991.91% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5764.6% through Dec 2025, changed N/A year-over-year, with the annual reading at 10211.14% for FY2023, 893782.0% down from the prior year.
  • EBT Margin for Q4 2025 was 15991.91% at Pliant Therapeutics, up from 3227.12% in the prior quarter.
  • The five-year high for EBT Margin was 15991.91% in Q4 2025, with the low at 16609.68% in Q2 2023.
  • Average EBT Margin over 4 years is 17.55%, with a median of 1251.68% recorded in 2021.
  • The sharpest move saw EBT Margin skyrocketed 68396bps in 2022, then plummeted -1601745bps in 2023.
  • Over 4 years, EBT Margin stood at 1227.16% in 2021, then tumbled by -45bps to 1784.22% in 2022, then plummeted by -831bps to 16609.68% in 2023, then skyrocketed by 196bps to 15991.91% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 15991.91%, 3227.12%, and 5352.29% for Q4 2025, Q3 2025, and Q2 2025 respectively.